Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Sotio Biotech Inc.
FindCure Biosciences (ZhongShan) Co., Ltd.
Adela, Inc
Eli Lilly and Company
Bayer
Actym Therapeutics, Inc.
Sensei Biotherapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Theratechnologies
Taproot Health
VitaMed Research LLC
Salubris Biotherapeutics Inc
NantCell, Inc.
TransThera Sciences (Nanjing), Inc.
Hoffmann-La Roche
Kineta Inc.
Blue Note Therapeutics
MacroGenics
Lumos Pharma
Celgene
Pfizer
Amgen
Valerio Therapeutics
Valerio Therapeutics
Calando Pharmaceuticals
Mannkind Corporation